Status:
UNKNOWN
Binaural Sound for Remimazolam Induction
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
General Anesthesia
Prostate Cancer
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
It is important to decrease the time-to-loss of consciousness and anesthetics dose of remimazolam for general anesthesia induction. We will evaluate the effect of binaural sound for general anestheia ...
Eligibility Criteria
Inclusion
- Patients scheduled for generla anesthesia
- Patients aged 20-60
- Patients with American Society of Anesthesiologist physical status classification 1-2
- Patients with ideal body weight 50-80 kg
Exclusion
- Patients with hearing disability
- Patients using opioids or sedatives in 1 week
- Patients who are dependent for alcoholics or drugs
- Patients with hypersensitivities to remimazolam
- Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
- Patients with liver failure
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06099977
Start Date
November 1 2023
End Date
October 30 2025
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GangnamSeveranceHospital
Seoul, South Korea